Owens & Minor Inc. reported its financial results for the second quarter of 2025, revealing a revenue increase to $681.9 million from $660.4 million in the same quarter of the previous year. The results primarily reflect the company's continuing operations, now focused on the Patient Direct segment after classifying its Products & Healthcare Services segment as discontinued operations. The company reported a GAAP net loss from continuing operations of $83.8 million for the quarter, a significant increase from the $6.7 million loss in the second quarter of 2024. On a non-GAAP basis, adjusted net income from continuing operations was $20.5 million, up from $19.3 million in the previous year. Owens & Minor's management, led by CEO Ed Pesicka, expressed optimism about the company's future as a pure-play Patient Direct business, citing favorable demographic trends and meaningful scale as factors supporting its growth and leadership in the market. The company plans to provide its 2025 financial outlook for continuing operations during an upcoming earnings conference call.